Vaccinex, Inc.
VCNX· OTC
VCNXVaccinex, Inc.
Filed Mar 9, 2020 · 10-K · 69 days after period end · 0001564590-20-009251
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|
| Revenue | $0.00 | $194.00K | — |
| Net Income | -$6.33M | -$8.45M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Vaccinex, Inc. · CIK 1205922 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 9, 2020 · 69 d after period end
